Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 28 4 2021
Statut: ppublish

Résumé

The purpose of this observational study was to evaluate the effects of radial artery access versus femoral artery access on the risk of 30-day mortality, inhospital bleeding and cardiogenic shock in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. We used data from the SWEDEHEART registry and included all patients who were treated with primary percutaneous coronary intervention in Sweden between 2005 and 2016. We compared patients who had percutaneous coronary intervention by radial access versus femoral access with regard to the primary endpoint of all-cause death within 30 days, using a multilevel propensity score adjusted logistic regression which included hospital as a random effect. During the study period, 44,804 patients underwent primary percutaneous coronary intervention of whom 24,299 (54.2%) had radial In patients with ST-elevation myocardial infarction, primary percutaneous coronary intervention by radial access rather than femoral access was associated with an adjusted lower risk of death, bleeding and cardiogenic shock. Our findings are consistent with, and add external validity to, recent randomised trials.

Identifiants

pubmed: 33025815
doi: 10.1177/2048872620908032
pmc: PMC7756052
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-332

Références

Eur Heart J. 2013 Feb;34(5):345-53
pubmed: 22947610
JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82
pubmed: 19926047
Circ Cardiovasc Interv. 2015 Jun;8(6):e002212
pubmed: 26047992
EuroIntervention. 2013 Mar;8(11):1242-51
pubmed: 23354100
J Am Coll Cardiol. 2017 May 11;:
pubmed: 28528767
J Cardiol. 2017 Jan;69(1):272-279
pubmed: 27269413
J Am Heart Assoc. 2017 Oct 28;6(11):
pubmed: 29080864
J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9
pubmed: 22858390
JAMA. 2013 Mar 13;309(10):1022-9
pubmed: 23483177
Lancet. 2015 Jun 20;385(9986):2465-76
pubmed: 25791214
Circulation. 2016 Apr 26;133(17):1655-67
pubmed: 26969759
N Engl J Med. 2006 Apr 6;354(14):1464-76
pubmed: 16537663
J Am Coll Cardiol. 2008 Feb 19;51(7):690-7
pubmed: 18279731
J Am Coll Cardiol. 2007 Mar 27;49(12):1362-8
pubmed: 17394970
Eur Heart J. 2010 Aug;31(15):1828-35
pubmed: 20610640
Circ Cardiovasc Interv. 2009 Jun;2(3):222-9
pubmed: 20031719
EuroIntervention. 2017 May 15;13(Z):Z8-Z10
pubmed: 28504221
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Int J Cardiol. 2013 Oct 3;168(3):2070-81
pubmed: 23490083
Eur Heart J. 2018 Jun 7;39(22):2090-2102
pubmed: 29554243
J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66
pubmed: 20513595
Exp Ther Med. 2015 Aug;10(2):809-815
pubmed: 26622398
JACC Cardiovasc Interv. 2013 Jul;6(7):698-706
pubmed: 23769648
Lancet. 2011 Apr 23;377(9775):1409-20
pubmed: 21470671
Am Heart J. 2012 Apr;163(4):632-48
pubmed: 22520530
Am J Cardiol. 2014 Feb 15;113(4):626-30
pubmed: 24355309
Circulation. 2013 Jan 29;127(4):e362-425
pubmed: 23247304
Am J Cardiol. 2018 Feb 1;121(3):279-288
pubmed: 29198986
Catheter Cardiovasc Interv. 2015 Oct;86 Suppl 1:S8-14
pubmed: 25945803
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Circulation. 2006 Aug 22;114(8):774-82
pubmed: 16908769
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
Catheter Cardiovasc Interv. 2007 Jun 1;69(7):961-6
pubmed: 17421023
Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1110-1120
pubmed: 29113720
Am J Cardiol. 2014 Sep 15;114(6):820-5
pubmed: 25073568
JACC Cardiovasc Interv. 2012 Jan;5(1):23-35
pubmed: 22230147
Curr Med Res Opin. 2013 Mar;29(3):189-94
pubmed: 23350949
Am J Cardiol. 2013 Nov 15;112(10):1533-9
pubmed: 23953696
Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):333-8
pubmed: 27050627
JACC Cardiovasc Interv. 2011 Feb;4(2):191-7
pubmed: 21349458
Heart. 2012 Apr;98(7):552-7
pubmed: 22337951
Lancet. 2009 Oct 3;374(9696):1149-59
pubmed: 19717185
Circulation. 2017 Oct 17;136(16):e232-e268
pubmed: 28923988
Eur Heart J. 2009 Apr;30(8):890-9
pubmed: 19299431
J Am Coll Cardiol. 2016 May 10;67(18):2145-2147
pubmed: 27151346
Cardiovasc Revasc Med. 2017 Apr - May;18(3):154-159
pubmed: 28119043
JACC Cardiovasc Interv. 2016 Jul 25;9(14):1517-8
pubmed: 27478124
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
J Am Coll Cardiol. 2013 Jan 29;61(4):420-426
pubmed: 23265340
Circulation. 2009 Apr 14;119(14):1873-82
pubmed: 19332461

Auteurs

Christian Dworeck (C)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Björn Redfors (B)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Sebastian Völz (S)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Inger Haraldsson (I)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Oskar Angerås (O)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Truls Råmunddal (T)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Dan Ioanes (D)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Anna Myredal (A)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Jacob Odenstedt (J)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Geir Hirlekar (G)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Sasha Koul (S)

Department of Cardiology, Clinical Sciences, Lund University, Sweden.

Ole Fröbert (O)

Department of Cardiology, Örebro University, Sweden.

Rickard Linder (R)

Department of Cardiology, Karolinska University Hospital, Sweden.

Dimitrios Venetsanos (D)

Department of Cardiology, Karolinska University Hospital, Sweden.

Robin Hofmann (R)

Department of Clinical Science and Education, Karolinska Institutet, Sweden.

Anders Ulvenstam (A)

Department of Cardiology, Östersund Hospital, Sweden.

Petur Petursson (P)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Giovanna Sarno (G)

Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Sweden.

Stefan James (S)

Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Sweden.

David Erlinge (D)

Department of Cardiology, Clinical Sciences, Lund University, Sweden.

Elmir Omerovic (E)

Department of Cardiology, Sahlgrenska University Hospital, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH